Caplin Point Laboratories Board of Directors

Get the latest insights into the leadership at Caplin Point Laboratories. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. C C Paarthipan Chairman
Dr. Sridhar Ganesan Managing Director
Dr. R Nagendran Independent Director
Mr. S Deenadayalan Independent Director
Mr. D Sathyanarayanan Independent Director
Dr. C K Gariyali Independent Director

Caplin Point Laboratories Share price

CAPLIPOINT

2156.2

71.70 (3.44%)
NSE
BSE
Last updated on 28 Aug, 2025 | 15:46 IST
BUYSELL
Today's High

2169.00

Today's Low

2071.40

52 Week Low

1599.00

52 Week High

2641.00

The current prices are delayed, login to your account for live prices

Caplin Point Laboratories FAQs

The board at Caplin Point Laboratories consists of experienced professionals, including Mr. C C Paarthipan , Dr. Sridhar Ganesan , and others, overseeing the company’s strategic and corporate governance.

Directors at Caplin Point Laboratories are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. C C Paarthipan is the current chairman at Caplin Point Laboratories.

Executive directors at Caplin Point Laboratories are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Caplin Point Laboratories adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Caplin Point Laboratories, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.